sample	event	source	type	chromosome1	bp1	chromosome2	bp2	split_reads	disc_reads	genotype	id	length(Kb)	position	configuration	allele_frequency	log2(cnv)	microhomology	inserted_seq	consensus	contig_sequence	mechanism	bp1_locus	bp2_locus	affected_genes	status	notes	snp_freq
D050R10	1	Control-Freec	DEL	2L	14731355	2L	14941435	-	-	somatic_tumour	-	210.1	2L:14731355-14941435	Heterozygous deletion	0.5	-0.44	-	-	-	-	-	intergenic	CG42313, intron	CR44857, CG31835, CG31775, CG42585, CG42586, CG34166, CG42681, CG42587, CR45460, CR45459, CR45458, CG4691, CR44858, CSN1a, CG4701, CG4650, CR15280, CG18636, CG18420, CG33308, CG33309, CR43805, CG42682, CG15279, CG4480, CG15278, CR45727, ProtA, ProtB, CR45302, CG3491, CG42313	aF	unadj_af=0.13; snp_su:236; snp_op:283; snp_ratio:0.83; wg_del:True	8.45
D050R10	2	Control-Freec	DEL	2L	15960020	2L	16209995	-	-	somatic_tumour	-	250.0	2L:15960020-16209995	Heterozygous deletion	0.5	-0.41	-	-	-	-	-	beat-Ib, intron	intergenic	beat-Ib, CR43803, CG10839, CR43412, beat-Ic, CR43825, CG34167, CR43826, CG43816, CG13245, CG31820, CR44844, CG45084, BicC, beat-Ia, CR44870, CG4891, CG4892, CG34168, CR44871, Ca-alpha1D, CR43806, CR44734, CR44735, CR44736	aF	unadj_af=0.12; snp_su:262; snp_op:337; snp_ratio:0.78; wg_del:True	7.88
D050R10	3	Control-Freec	DEL	2L	16963960	2L	17286150	-	-	somatic_tumour	-	322.2	2L:16963960-17286150	Heterozygous deletion	0.5	-0.65	-	-	-	-	-	intergenic	intergenic	CR45285, beat-IIIb, CG44406, CR44408, CG31806, CR45356, CR45357, CG6304, CR45462, CR43802, CG15136, CR43819, CG12620, CR45448, CG31784, beat-IIIa, CG34106, CG34169, CR44394, Gr36a, Gr36b, Gr36c, CG31750, beat-IIIc, CR44396, CR44395, CR45729	aF	unadj_af=0.18; snp_su:428; snp_op:407; snp_ratio:1.05; wg_del:True	9.53
D050R10	4	Control-Freec	DEL	2L	17530570	2L	17948205	-	-	somatic_tumour	-	417.6	2L:17530570-17948205	Heterozygous deletion	0.5	-0.69	-	-	-	-	-	CG15145, exon	CR44398, exon_2	CG15145, CR43304, CR45697, CG7094, CR45919, mir-124, mir-287, CR45358, CR45698, CR45111, CR45112, CR44411, Oli, CR44410, CG6870, Sytalpha, CR44412, CR44413, CG15147, CG43054, CR45699, CadN, CG43231, CadN2, CR43419, CG42830, CR43420, CR45332, CR45333, CG43271, CR43274, CR44399, CR44398	aF	unadj_af=0.19; snp_su:567; snp_op:636; snp_ratio:0.89; wg_del:True	8.97
D050R10	5	Control-Freec	DEL	3L	9102625	3L	9106160	-	-	somatic_tumour	-	3.5	3L:9102625-9106160	Heterozygous deletion	0.5	-0.94	-	-	-	-	-	bol, 3UTR	bol, intron	bol		unadj_af=0.24; snp_su:18; snp_op:2; snp_ratio:8.96; wg_del:True	26.53
D050R10	8	Control-Freec	DEL	3R	32031140	3R	32079331	-	-	somatic_tumour	-	48.2	3R:32031140-32079331	Heterozygous deletion	0.5	-0.45	-	-	-	-	-	intergenic	intergenic	CG2053, krz, mod, Map205	aF	unadj_af=0.13; snp_su:17; snp_op:30; snp_ratio:0.57; wg_del:True	7.23
D050R10	10	Control-Freec	DEL	X	11195850	X	11199385	-	-	somatic_tumour	-	3.5	X:11195850-11199385	Heterozygous deletion	0.5	-0.9	-	-	-	-	-	intergenic	intergenic	-		unadj_af=0.25; snp_su:0; snp_op:0; wg_del:True	0.0
D050R12	4	Control-Freec	DEL	3R	32031456	3R	32079331	-	-	somatic_tumour	-	47.9	3R:32031456-32079331	Heterozygous deletion	0.5	-0.48	-	-	-	-	-	intergenic	intergenic	CG2053, krz, mod, Map205		unadj_af=0.13; snp_su:25; snp_op:19; snp_ratio:1.32; wg_del:True	10.77
D050R12	6	Control-Freec	DUP	X	6268144	X	6274032	-	-	somatic_tumour	-	5.9	X:6268144-6274032	Heterozygous duplication	0.5	0.44	-	-	-	-	-	Spt6, exon_2	Spt6, exon	Spt6		unadj_af=0.19; snp_su:0; snp_op:0	0.0
D050R12	7	Control-Freec	DEL	X	11196032	X	11199344	-	-	somatic_tumour	-	3.3	X:11196032-11199344	Heterozygous deletion	0.5	-0.86	-	-	-	-	-	intergenic	intergenic	-		unadj_af=0.24; snp_su:0; snp_op:2; wg_del:True	0.0
D050R14	3	Control-Freec	DEL	2L	16953234	2L	17324619	-	-	somatic_tumour	-	371.4	2L:16953234-17324619	Heterozygous deletion	0.5	-0.57	-	-	-	-	-	intergenic	intergenic	CR45285, beat-IIIb, CG44406, CR44408, CG31806, CR45356, CR45357, CG6304, CR45462, CR43802, CG15136, CR43819, CG12620, CR45448, CG31784, beat-IIIa, CG34106, CG34169, CR44394, Gr36a, Gr36b, Gr36c, CG31750, beat-IIIc, CR44396, CR44395, CR45729, CG15140, CG6380, CG34170, CR45696, CG45691	aF	unadj_af=0.16; snp_su:493; snp_op:559; snp_ratio:0.88; wg_del:True	8.59
D050R14	4	Control-Freec	DEL	2L	17531337	2L	17942415	-	-	somatic_tumour	-	411.1	2L:17531337-17942415	Heterozygous deletion	0.5	-0.63	-	-	-	-	-	CG15145, exon	intergenic	CG15145, CR43304, CR45697, CG7094, CR45919, mir-124, mir-287, CR45358, CR45698, CR45111, CR45112, CR44411, Oli, CR44410, CG6870, Sytalpha, CR44412, CR44413, CG15147, CG43054, CR45699, CadN, CG43231, CadN2, CR43419, CG42830, CR43420, CR45332, CR45333, CG43271, CR43274, CR44399	aF	unadj_af=0.17; snp_su:430; snp_op:523; snp_ratio:0.82; wg_del:True	8.23
D050R14	5	Control-Freec	DEL	3L	9102666	3L	9106596	-	-	somatic_tumour	-	3.9	3L:9102666-9106596	Heterozygous deletion	0.5	-0.94	-	-	-	-	-	bol, 3UTR	bol, 3UTR	bol		unadj_af=0.24; snp_su:20; snp_op:2; snp_ratio:9.96; wg_del:True	22.8
D050R14	7	Control-Freec	DEL	3R	32041683	3R	32079331	-	-	somatic_tumour	-	37.6	3R:32041683-32079331	Heterozygous deletion	0.5	-0.64	-	-	-	-	-	intergenic	intergenic	krz, mod, Map205	aF	unadj_af=0.17; snp_su:11; snp_op:18; snp_ratio:0.61; wg_del:True	7.06
D050R14	9	Control-Freec	DUP	4	328941	4	330120	-	-	somatic_tumour	-	1.2	4:328941-330120	Heterozygous duplication	0.5	0.44	-	-	-	-	-	PMCA, 3UTR	PMCA, 3UTR	CG32850, PMCA		unadj_af=0.2; snp_su:0; snp_op:0	0.0
D050R16	2	Control-Freec	DEL	2L	14743100	2L	14974944	-	-	somatic_tumour	-	231.8	2L:14743100-14974944	Heterozygous deletion	0.5	-0.47	-	-	-	-	-	intergenic	CR45331, ncRNA	CG34166, CG42681, CG42587, CR45460, CR45459, CR45458, CG4691, CR44858, CSN1a, CG4701, CG4650, CR15280, CG18636, CG18420, CG33308, CG33309, CR43805, CG42682, CG15279, CG4480, CG15278, CR45727, ProtA, ProtB, CR45302, CG42313, CG3491, CR45331	aF	unadj_af=0.13; snp_su:276; snp_op:294; snp_ratio:0.94; wg_del:True	9.31
D050R16	3	Control-Freec	DEL	2L	15983621	2L	16199516	-	-	somatic_tumour	-	215.9	2L:15983621-16199516	Heterozygous deletion	0.5	-0.47	-	-	-	-	-	intergenic	intergenic	CR43412, beat-Ic, CR43825, CG34167, CR43826, CG13245, CG43816, CG31820, CR44844, BicC, CG45084, beat-Ia, CR44870, CG4891, CG4892, CG34168, CR44871, Ca-alpha1D, CR43806, CR44734, CR44735	aF	unadj_af=0.12; snp_su:267; snp_op:298; snp_ratio:0.9; wg_del:True	9.15
D050R16	4	Control-Freec	DEL	2L	16963901	2L	17321392	-	-	somatic_tumour	-	357.5	2L:16963901-17321392	Heterozygous deletion	0.5	-0.68	-	-	-	-	-	intergenic	intergenic	CR45285, beat-IIIb, CG44406, CR44408, CG31806, CR45356, CR45357, CG6304, CR45462, CR43802, CG15136, CR43819, CG12620, CR45448, CG31784, CG34106, beat-IIIa, CG34169, CR44394, Gr36a, Gr36b, Gr36c, CG31750, beat-IIIc, CR44396, CR44395, CR45729, CG15140, CG6380, CG34170, CR45696, CG45691	aF	unadj_af=0.18; snp_su:463; snp_op:537; snp_ratio:0.86; wg_del:True	8.81
D050R16	5	Control-Freec	DEL	2L	17533397	2L	17942625	-	-	somatic_tumour	-	409.2	2L:17533397-17942625	Heterozygous deletion	0.5	-0.74	-	-	-	-	-	intergenic	intergenic	CR43304, CR45697, CG7094, CR45919, mir-124, mir-287, CR45358, CR45698, CR45111, CR45112, CR44411, Oli, CR44410, CG6870, Sytalpha, CR44412, CR44413, CG15147, CG43054, CR45699, CadN, CG43231, CadN2, CR43419, CG42830, CR43420, CR45332, CR45333, CG43271, CR43274, CR44399	aF	unadj_af=0.19; snp_su:436; snp_op:478; snp_ratio:0.91; wg_del:True	8.75
D050R16	7	Control-Freec	DUP	2R	21820177	2R	21830291	-	-	somatic_tumour	-	10.1	2R:21820177-21830291	Heterozygous duplication	0.5	0.41	-	-	-	-	-	intergenic	CG13492, intron	CG13492		unadj_af=0.16; snp_su:0; snp_op:0	0.0
D050R16	10	Control-Freec	DEL	3L	0	3L	110087	-	-	somatic_tumour	-	110.1	3L:0-110087	Heterozygous deletion	0.5	-0.5	-	-	-	-	-	intergenic	intergenic	mthl8, CG43149, Lsp1gamma, CR44510, CR44511, CR43150, CR43988, CG13405, CG12483	aF	unadj_af=0.14; snp_su:41; snp_op:49; snp_ratio:0.84; wg_del:True	8.17
D050R16	13	Control-Freec	DEL	3R	32031038	3R	32079331	-	-	somatic_tumour	-	48.3	3R:32031038-32079331	Heterozygous deletion	0.5	-0.75	-	-	-	-	-	intergenic	intergenic	CG2053, krz, mod, Map205	aF	unadj_af=0.19; snp_su:21; snp_op:22; snp_ratio:0.95; wg_del:True	8.02
D050R16	15	Control-Freec	DUP	X	9363230	X	9373733	-	-	somatic_tumour	-	10.5	X:9363230-9373733	Heterozygous duplication	0.5	0.53	-	-	-	-	-	mgl, exon_12	mgl, exon_7	mgl		unadj_af=0.23; snp_su:0; snp_op:0	0.0
D050R16	17	Control-Freec	DUP	X	20392158	X	20410830	-	-	somatic_tumour	-	18.7	X:20392158-20410830	Heterozygous duplication	0.5	0.42	-	-	-	-	-	l(1)G0004, exon	HERC2, exon_9	l(1)G0004, Syx16, HERC2		unadj_af=0.18; snp_su:0; snp_op:0	0.0
D050R18	3	Control-Freec	DUP	2L	8538675	2L	8543670	-	-	somatic_tumour	-	5.0	2L:8538675-8543670	Heterozygous duplication	0.5	0.57	-	-	-	-	-	CG17834, intron	Sema-1a, exon_1	CG17834, tRNA:Asp-GTC-1-4, tRNA:Asp-GTC-1-5, Sema-1a		unadj_af=0.13; snp_su:0; snp_op:0	0.0
D050R18	4	Control-Freec	DUP	2L	10278600	2L	10281930	-	-	somatic_tumour	-	3.3	2L:10278600-10281930	Heterozygous duplication	0.5	0.48	-	-	-	-	-	Utx, intron	intergenic	Utx, CG34043		unadj_af=0.23; snp_su:0; snp_op:0	0.0
D050R18	5	Control-Freec	DUP	2L	10291920	2L	10293585	-	-	somatic_tumour	-	1.7	2L:10291920-10293585	Heterozygous duplication	0.5	0.6	-	-	-	-	-	CG5604, intron	Hand, intron	CG5604, Hand		unadj_af=0.3; snp_su:0; snp_op:0	0.0
D050R18	6	Control-Freec	DUP	2L	10995660	2L	10997880	-	-	somatic_tumour	-	2.2	2L:10995660-10997880	Heterozygous duplication	0.5	0.78	-	-	-	-	-	CG16833, 3UTR	aub, 3UTR	CG16833, aub		unadj_af=0.37; snp_su:0; snp_op:0	0.0
D050R18	8	novobreak	BND	2L	11516068	2L	11516283	6	0	somatic_tumour	2	0.2	2L:11516068-11516283	5to5	0.11	0.0	-	-	CTTCCCTTTTTTCTACACTTCGCCACCTATCCCCATTCTCCCTACTGCCAACCCACTGCATTTTATCTAAAATAAACTGTAACTTTTTGTTAACTTTACTAGTAATACTATTTTGACCATTGCTGTATTTTTTGAAGTGTGCGAGTAAGTATGAAAAGCAAGGCATTGGAAAAACGAAACTTTCACAATTTTTGTGAAACCGCGA	-	-	Dlg5, intron	Dlg5, intron	Dlg5		unadj_af=0.11	0.0
D050R18	9	Control-Freec	DUP	2L	11793750	2L	11795970	-	-	somatic_tumour	-	2.2	2L:11793750-11795970	Heterozygous duplication	0.5	0.62	-	-	-	-	-	CG14937, exon	crol, 3UTR	CG14937, crol		unadj_af=0.23; snp_su:0; snp_op:1	0.0
D050R18	10	Control-Freec	DUP	2L	14517690	2L	14528790	-	-	somatic_tumour	-	11.1	2L:14517690-14528790	Heterozygous duplication	0.5	0.47	-	-	-	-	-	intergenic	intergenic	tRNA:Gly-GCC-1-4, tRNA:Gly-GCC-1-5, tRNA:Gly-GCC-1-6, CG33648		unadj_af=0.18; snp_su:8; snp_op:9; snp_ratio:0.89	10.44
D050R18	11	Control-Freec	DUP	2L	15032730	2L	15034950	-	-	somatic_tumour	-	2.2	2L:15032730-15034950	Heterozygous duplication	0.5	0.57	-	-	-	-	-	GABA-B-R1, 3UTR	intergenic	GABA-B-R1		unadj_af=0.24; snp_su:1; snp_op:0	12.4
D050R18	12	Control-Freec	DUP	2L	17457525	2L	17461410	-	-	somatic_tumour	-	3.9	2L:17457525-17461410	Heterozygous duplication	0.5	0.5	-	-	-	-	-	CG18563, exon	BicD, exon_8	CG5050, CG18563, BicD		unadj_af=0.19; snp_su:1; snp_op:1	5.88
D050R18	16	Control-Freec	DUP	3L	5744805	3L	5750355	-	-	somatic_tumour	-	5.5	3L:5744805-5750355	Heterozygous duplication	0.5	0.48	-	-	-	-	-	sif, 3UTR	DnaJ-1, 3UTR	sif, DnaJ-1	aF	unadj_af=0.18; snp_su:3; snp_op:5; snp_ratio:0.6	7.57
D050R18	18	Control-Freec	DUP	3L	16197675	3L	16202115	-	-	somatic_tumour	-	4.4	3L:16197675-16202115	Heterozygous duplication	0.5	0.67	-	-	-	-	-	intergenic	intergenic	CG33687, CG33688, CG33689, CG33690		unadj_af=0.27; snp_su:6; snp_op:3; snp_ratio:2.0	15.54
D050R18	21	Control-Freec	DUP	3R	14618145	3R	14620920	-	-	somatic_tumour	-	2.8	3R:14618145-14620920	Heterozygous duplication	0.5	0.73	-	-	-	-	-	CG14853, 3UTR	put, 3UTR	CG14853, put		unadj_af=0.34; snp_su:0; snp_op:0	0.0
D050R18	22	novobreak	BND	3R	20367342	3R	20367486	3	0	somatic_tumour	14	0.1	3R:20367342-20367486	3to3	0.04	0.0	-	-	CCTTAGTGGAGTTCCATACCCCGCAGACCCTTCCCCAGGAAGCTCAGAAATTCCCCCCCAAACCCCAAAACAGTTCGCAAGTTTTCACAAGAGTGCCTAGCCAAAAAAGGGGGGAAGGACGCACAAGCGCCAAACGAGGCTGGCAAAACGTCGAAAACAAGAAATCAGAAAATCAGATGTAGCTGCGATTCTCACAATCGGACGCACTGATGTGTATAATGATCTTTAGCTGGGATTTAAAACG	-	-	intergenic	intergenic	-		unadj_af=0.04	0.0
D050R18	23	Control-Freec	DUP	4	235875	4	253635	-	-	somatic_tumour	-	17.8	4:235875-253635	Heterozygous duplication	0.5	0.46	-	-	-	-	-	CG1674, intron	intergenic	CG1674, dpr7		unadj_af=0.16; snp_su:0; snp_op:0	0.0
D050R18	24	Control-Freec	DUP	4	570540	4	572205	-	-	somatic_tumour	-	1.7	4:570540-572205	24:24_25	0.5	0.64	-	-	-	-	-	ND-49, intron	Ephrin, intron	ND-49, Ephrin		unadj_af=0.35; snp_su:0; snp_op:0	0.0
D050R18	26	Control-Freec	DUP	4	810855	4	812520	-	-	somatic_tumour	-	1.7	4:810855-812520	26:26_27	0.5	0.67	-	-	-	-	-	Sox102F, intron	Sox102F, intron	Sox102F		unadj_af=0.36; snp_su:0; snp_op:0	0.0
D050R18	26	Control-Freec	DUP	4	812520	4	831945	-	-	somatic_tumour	-	19.4	4:812520-831945	27:26_27	0.5	0.43	-	-	-	-	-	Sox102F, intron	Sox102F, intron	Sox102F		unadj_af=0.14; snp_su:0; snp_op:0	0.0
D050R18	28	Control-Freec	DUP	4	892995	4	897435	-	-	somatic_tumour	-	4.4	4:892995-897435	28:28_29	0.5	0.56	-	-	-	-	-	unc-13, intron	unc-13, intron	unc-13		unadj_af=0.25; snp_su:0; snp_op:0	0.0
D050R18	31	Control-Freec	DUP	X	13071915	X	13074690	-	-	somatic_tumour	-	2.8	X:13071915-13074690	Heterozygous duplication	0.5	0.54	-	-	-	-	-	rad, intron	rad, intron	rad		unadj_af=0.26; snp_su:0; snp_op:0	0.0
D050R20	1	novobreak	BND	2L	15334268	2L	15343758	7	0	somatic_tumour	2	9.5	2L:15334268-15343758	5to5	0.05	0.17	-	-	GCTCTAGGCATCCTCTGCACCTGAAAAAATTATTCAGTATCCTAGAATACGCTGTATAAATGGTATATGCAAGCTAGAAGTAATCAAAACAGTTAGGCTGATCAACGTCAGCGATTGTTGCGAGGACGAGGGTGTGGATGTGGATCATACAGATGATGAACACATCGAGGAAGAGGACGAGGACGTCGATGTGGATGTGGACTCGGACCCCAATCAGACCCAGGCTGCGGCT	-	-	esg, exon	intergenic	esg		unadj_af=0.05	0.0
D050R20	5	novobreak	BND	3L	12212180	3L	12212290	4	0	somatic_tumour	7	0.1	3L:12212180-12212290	3to3	0.03	0.0	-	-	GTTGCGGCGAATAGTATTTGAAGTCCGTGGGCGCCGGCGCTTGCGGCGCCGCAGTGTGTATGGTGGTCAGAGTGCTGTTGCTGGCGGAGATTGCTCCGCTGGCCTGCAGCTGCAGCGTCGACGGGCGTCGTGGCGCCAGCGGCACCAATACCGGTACCGGCACTGGTACGGGTGGTTCCTCCTCCTCCGCCACCACCACCG	-	-	app, exon	app, exon	app		unadj_af=0.03	0.0
D050R20	6	lumpy	DEL	3L	21411443	3L	21412383	11	2	somatic_tumour	4949	0.9	3L:21411443-21412383	5to3	0.09	-0.2	-	-	-	-	-	rgn, intron	rgn, intron	rgn		unadj_af=0.09; wg_del:True	0.0
D050R20	7	Control-Freec	DUP	3R	5147556	3R	5151408	-	-	somatic_tumour	-	3.9	3R:5147556-5151408	Heterozygous duplication	0.5	0.71	-	-	-	-	-	intergenic	dpr16, intron	dpr16		unadj_af=0.32; snp_su:0; snp_op:2	0.0
D050R20	13	Control-Freec	DUP	4	798220	4	799504	-	-	somatic_tumour	-	1.3	4:798220-799504	Heterozygous duplication	0.5	0.49	-	-	-	-	-	intergenic	intergenic	-		unadj_af=0.24; snp_su:0; snp_op:1	0.0
D050R20	15	Control-Freec	DUP	X	10435068	X	10436352	-	-	somatic_tumour	-	1.3	X:10435068-10436352	Heterozygous duplication	0.5	0.44	-	-	-	-	-	CG32683, intron	CG32683, intron	CG32683		unadj_af=0.32; snp_su:0; snp_op:0	0.0
D050R20	17	novobreak	TRA	X	10822149	3R	22494715	3	0	somatic_tumour	52	11672.6	X:10822149 3R:22494715	5to5	0.05	0.0	-	-	GAGTTGTCACCTACACAAAAATCAATAACGAAACCCAATAAAATAAAATCCCACTAAATACTGTTCCATATATCAAGGCTTAACCGTAGAAGCAACAGCCATAAAGTCCGGCTGATTGCAAACAATTCCGATTGATTTATTGTGGCAATGGTTAATAC	-	-	Imp, intron	intergenic	Imp		unadj_af=0.05	0.0
D050R20	21	Control-Freec	DEL	X	21557932	X	21571200	-	-	somatic_tumour	-	13.3	X:21557932-21571200	Heterozygous deletion	0.5	-0.55	-	-	-	-	-	intergenic	intergenic	-		unadj_af=0.16; snp_su:0; snp_op:0; wg_del:True	0.0
D050R22	1	novobreak	DEL	2L	140255	2L	144791	3	0	somatic_tumour	1	4.5	2L:140255-144791	5to3	0.01	-0.12	-	-	AAAGGCCCATCGGGTCTATCTGGGGCGGCTGCTAAGAATTCAAAAAACTGGTCCGACAACTCTTTCATTCGGGCTACAAGTCTGGAGTCTACCAAGTCGTCACATTCCTGCTGAAGGCTGGTGGACTTCAGCGAGAACAGCTCCGCAGCTGCTTGGCAGGAAGCTCGAGCTACTTGGG	-	-	CG31976, exon_1	CG42399, exon	ND-15, CG31975, CG31976, CG42399		unadj_af=0.01; bp1_roo_BEL=13; wg_del:True	0.0
D050R22	2	delly	DEL	2L	3788744	2L	3790516	12	1	somatic_tumour	DEL00000000	1.8	2L:3788744-3790516	5to3	0.1	-0.03	6	-	GGGCAATAATTAGACCTCAAACGAGCATAAAATTGTTTAGCCAATTGGCATTATTCTAACAACATTAGTTCAGAGGGTTGTTGAACTCTTCGGTAGAACGGAAACTAAACCTTTTCCCCCAAACAGCTGTTAAATAATCACGAAACTGCCATGGCGAATGTGTAATAAAAACCGTTAGTGAAGTAGTTAATTGAAAGCAAAAATAAACCA	-	-	bark, intron	bark, intron	bark		unadj_af=0.1; wg_del:True	0.0
D050R22	2	lumpy	DEL	2L	3788744	2L	3790516	12	1	somatic_tumour	512	1.8	2L:3788744-3790516	5to3	0.1	-0.03	-	-	-	-	-	bark, intron	bark, intron	bark		unadj_af=0.1; wg_del:True	0.0
D050R22	3	Control-Freec	DUP	2R	3897936	2R	3943296	-	-	somatic_tumour	-	45.4	2R:3897936-3943296	Heterozygous duplication	0.5	0.28	-	-	-	-	-	intergenic	uex, exon_3	uex	T	unadj_af=0.1; low FC; snp_su:10; snp_op:4; snp_ratio:2.5	11.97
D050R22	4	Control-Freec	DUP	2R	10492776	2R	10499832	-	-	somatic_tumour	-	7.1	2R:10492776-10499832	Heterozygous duplication	0.5	0.51	-	-	-	-	-	lola, intron	lola, intron	lola		unadj_af=0.2; snp_su:0; snp_op:5; snp_ratio:0.0	0.0
D050R22	10	Control-Freec	DUP	4	71568	4	75600	-	-	somatic_tumour	-	4.0	4:71568-75600	Heterozygous duplication	0.5	0.56	-	-	-	-	-	pan, intron	pan, intron	pan		unadj_af=0.22; snp_su:1; snp_op:1	5.01
D050R22	11	Control-Freec	DUP	4	553392	4	577584	-	-	somatic_tumour	-	24.2	4:553392-577584	Heterozygous duplication	0.5	0.33	-	-	-	-	-	Thd1, exon_2	Ephrin, 3UTR	Thd1, CR43958, Pur-alpha, ND-49, Ephrin	T	unadj_af=0.13; low FC; snp_su:6; snp_op:2; snp_ratio:2.99	14.3
D050R22	12	Control-Freec	DUP	4	983808	4	988848	-	-	somatic_tumour	-	5.0	4:983808-988848	Heterozygous duplication	0.5	0.41	-	-	-	-	-	intergenic	intergenic	-		unadj_af=0.16; snp_su:0; snp_op:1	0.0
D050R22	13	Control-Freec	DUP	4	1051848	4	1054368	-	-	somatic_tumour	-	2.5	4:1051848-1054368	Heterozygous duplication	0.5	0.52	-	-	-	-	-	CaMKII, intron	intergenic	CaMKII		unadj_af=0.24; snp_su:0; snp_op:0	0.0
D050R22	15	Control-Freec	DUP	X	3335976	X	3354624	-	-	somatic_tumour	-	18.6	X:3335976-3354624	Heterozygous duplication	0.5	0.53	-	-	-	-	-	CR44886, ncRNA	intergenic	dnc, CR44886		unadj_af=0.21; snp_su:0; snp_op:0	0.0
D050R22	17	novobreak	BND	X	15470322	X	15495936	7	0	somatic_tumour	8	25.6	X:15470322-15495936	5to5	0.08	0.02	-	-	ATATAACTTCATATATAGCTAGTTATATTGATAATATACCATATAAAAAAAGGTTAACCAATGCAGGGATATAACAGTTACTATTTTAAGACCACTTTTCCATTGATCATTGATCGTTTTGGAAAAATACCACAAATAGTTTTACCAACACCACCAGCTGGCTAAAATGTTCCCTGAACTCAATCGTAAAACGGATCAGTGTATTTTTCGCTGGATCCTTATTGACACGATCCTCGTAAGCGATGAGGAGCTGGCAAATGGGCTGGACAAGATCTCTCAGGCCGTATGCAAAGA	-	-	Grip128, exon_4	Gmap, intron	Grip128, Gmap		unadj_af=0.08	0.0
D050R24	2	Control-Freec	DUP	2L	3453030	2L	3469734	-	-	somatic_tumour	-	16.7	2L:3453030-3469734	Heterozygous duplication	0.5	0.52	-	-	-	-	-	CG12795, exon_2	CG3238, exon_1	CG12795, Cog3, Sec5, CG3246, msl-2, mir-4971, ND-PDSW, CG3238	aF	unadj_af=0.23; snp_su:40; snp_op:81; snp_ratio:0.49	5.1
D050R24	4	Control-Freec	DUP	2L	6970266	2L	6985404	-	-	somatic_tumour	-	15.1	2L:6970266-6985404	Heterozygous duplication	0.5	0.75	-	-	-	-	-	snRNP-U1-70K, exon	uif, intron	snRNP-U1-70K, CR43142, uif	aF	unadj_af=0.37; snp_su:25; snp_op:40; snp_ratio:0.63	5.86
D050R24	10	Control-Freec	DUP	2R	13872150	2R	13894596	-	-	somatic_tumour	-	22.4	2R:13872150-13894596	Heterozygous duplication	0.5	0.45	-	-	-	-	-	shot, exon_20	shot, intron	shot	aF	unadj_af=0.19; snp_su:65; snp_op:122; snp_ratio:0.53	5.7
D050R24	12	Control-Freec	DUP	2R	14415552	2R	14433300	-	-	somatic_tumour	-	17.7	2R:14415552-14433300	Heterozygous duplication	0.5	0.43	-	-	-	-	-	intergenic	intergenic	CG17386, phyl	aF	unadj_af=0.17; snp_su:18; snp_op:40; snp_ratio:0.45	5.16
D050R24	13	Control-Freec	DUP	2R	18269478	2R	18288792	-	-	somatic_tumour	-	19.3	2R:18269478-18288792	Heterozygous duplication	0.5	0.51	-	-	-	-	-	intergenic	CG14502, exon_1	Ote, pen-2, sbb, CG14502	aF	unadj_af=0.22; snp_su:55; snp_op:61; snp_ratio:0.9	7.77
D050R24	16	Control-Freec	DUP	2R	23355324	2R	23402304	-	-	somatic_tumour	-	47.0	2R:23355324-23402304	Heterozygous duplication	0.5	0.44	-	-	-	-	-	Rpi, 5UTR	CG3520, exon_1	Rpi, CG3500, CG9875, CR44168, CG34423, CG34424, vir, Ice1, Golgin245, CG13551, yellow-d, yellow-d2, CR44784, CG30414, roh, eIF2B-delta, CG3530, CG3520	aF	unadj_af=0.19; snp_su:24; snp_op:28; snp_ratio:0.86	6.61
D050R24	17	Control-Freec	DEL	3L	0	3L	106488	-	-	somatic_tumour	-	106.5	3L:0-106488	Heterozygous deletion	0.5	-0.53	-	-	-	-	-	intergenic	intergenic	mthl8, CG43149, Lsp1gamma, CR44510, CR44511, CR43150, CR43988, CG13405, CG12483		unadj_af=0.16; snp_su:46; snp_op:38; snp_ratio:1.21; wg_del:True	10.51
D050R24	22	Control-Freec	DUP	3L	8465274	3L	8467884	-	-	somatic_tumour	-	2.6	3L:8465274-8467884	22:22_23	0.5	0.94	-	-	-	-	-	Gug, exon_5	Gug, exon_5	Gug	aF	unadj_af=0.47; snp_su:2; snp_op:6; snp_ratio:0.33	4.77
D050R24	26	Control-Freec	DUP	3L	13498920	3L	13507794	-	-	somatic_tumour	-	8.9	3L:13498920-13507794	Heterozygous duplication	0.5	0.69	-	-	-	-	-	Tgi, intron	Spt20, exon_5	Tgi, Spt20	aF	unadj_af=0.31; snp_su:5; snp_op:9; snp_ratio:0.56	5.08
D050R24	30	Control-Freec	DUP	3R	11226654	3R	11231352	-	-	somatic_tumour	-	4.7	3R:11226654-11231352	Heterozygous duplication	0.5	0.69	-	-	-	-	-	scpr-C, 3UTR	CG17187, exon	scpr-C, CG17726, GCC88, CG17187	aF	unadj_af=0.34; snp_su:0; snp_op:11; snp_ratio:0.0	0.0
D050R24	31	Control-Freec	DUP	3R	11371248	3R	11376990	-	-	somatic_tumour	-	5.7	3R:11371248-11376990	Heterozygous duplication	0.5	0.74	-	-	-	-	-	pros, intron	pros, exon_5	pros		unadj_af=0.36; snp_su:0; snp_op:1	0.0
D050R24	34	Control-Freec	DUP	3R	24318414	3R	24329376	-	-	somatic_tumour	-	11.0	3R:24318414-24329376	Heterozygous duplication	0.5	0.54	-	-	-	-	-	Nab2, 5UTR	CG5728, exon_3	Nab2, CR46093, BRWD3, CG5728		unadj_af=0.23; snp_su:1; snp_op:1	9.28
D050R24	35	Control-Freec	DUP	3R	24615954	3R	24663978	-	-	somatic_tumour	-	48.0	3R:24615954-24663978	Heterozygous duplication	0.5	0.46	-	-	-	-	-	mld, intron	slo, intron	mld, Syx18, atl, Wsck, CG43222, puf, ash2, CG31125, CG6695, mir-1003, CG31126, Ppox, slo	aF	unadj_af=0.19; snp_su:65; snp_op:107; snp_ratio:0.61	5.84
D050R24	38	Control-Freec	DUP	3R	29487258	3R	29495088	-	-	somatic_tumour	-	7.8	3R:29487258-29495088	Heterozygous duplication	0.5	0.78	-	-	-	-	-	CG2321, intron	CG2010, exon_2	CG2321, CG2006, Spase12, CG2310, Diedel, CG2010	aF	unadj_af=0.35; snp_su:15; snp_op:32; snp_ratio:0.47	4.59
D050R24	40	Control-Freec	DEL	4	266220	4	292320	-	-	somatic_tumour	-	26.1	4:266220-292320	Heterozygous deletion	0.5	-0.41	-	-	-	-	-	intergenic	Syt7, intron	NfI, CR44023, Syt7		unadj_af=0.14; snp_su:0; snp_op:0; wg_del:True	0.0
D050R24	41	Control-Freec	DEL	4	728190	4	729756	-	-	somatic_tumour	-	1.6	4:728190-729756	Heterozygous deletion	0.5	-0.71	-	-	-	-	-	bt, exon_5	bt, intron	bt		unadj_af=0.2; snp_su:0; snp_op:0; wg_del:True; wg_del:True	0.0
D050R24	42	Control-Freec	DEL	4	898362	4	903582	-	-	somatic_tumour	-	5.2	4:898362-903582	Heterozygous deletion	0.5	-0.42	-	-	-	-	-	unc-13, intron	unc-13, intron	unc-13		unadj_af=0.13; snp_su:0; snp_op:0; wg_del:True; wg_del:True	0.0
D050R24	44	Control-Freec	DUP	X	2724840	X	2737890	-	-	somatic_tumour	-	13.1	X:2724840-2737890	Heterozygous duplication	0.5	0.51	-	-	-	-	-	fs(1)Ya, exon	crm, intron	fs(1)Ya, vilya, dwg, ttm50, CG2712, crm		unadj_af=0.24; snp_su:0; snp_op:0	0.0
D050R24	45	Control-Freec	DUP	X	4619700	X	4660416	-	-	somatic_tumour	-	40.7	X:4619700-4660416	Heterozygous duplication	0.5	0.48	-	-	-	-	-	peb, intron	CG3009, exon_2	peb, CG12184, CG12179, pon, CG3081, CG3062, HLH4C, mRpL30, Torsin, Cbp80, CG15473, CG3009		unadj_af=0.2; snp_su:1; snp_op:0	21.43
D050R24	48	Control-Freec	DUP	X	5312916	X	5329098	-	-	somatic_tumour	-	16.2	X:5312916-5329098	Heterozygous duplication	0.5	0.55	-	-	-	-	-	dhd, 3UTR	CG3309, exon_1	dhd, CG4198, CG15930, Sas10, Rnp4F, Mcm3, CG3309		unadj_af=0.24; snp_su:0; snp_op:0	0.0
D050R24	49	Control-Freec	DUP	X	6083388	X	6114708	-	-	somatic_tumour	-	31.3	X:6083388-6114708	Heterozygous duplication	0.5	0.5	-	-	-	-	-	Mipp2, 3UTR	Ca-alpha1T, exon_19	raptor, Mipp2, CR44959, Nep1, Ca-alpha1T		unadj_af=0.21; snp_su:0; snp_op:1	0.0
D050R24	50	Control-Freec	DUP	X	8125452	X	8168256	-	-	somatic_tumour	-	42.8	X:8125452-8168256	Heterozygous duplication	0.5	0.47	-	-	-	-	-	cyr, intron	CG2278, exon	cyr, CG2116, CG10958, CG2120, Smox, CG17982, alpha-PheRS, CG2129, CG15336, CG10959, Gbeta5, CG18262, Traf6, GIIIspla2, CG15337, CG10761, CR45536, Or7a, CG2278		unadj_af=0.21; snp_su:0; snp_op:0	0.0
D050R24	51	Control-Freec	DUP	X	10465578	X	10470798	-	-	somatic_tumour	-	5.2	X:10465578-10470798	Heterozygous duplication	0.5	0.75	-	-	-	-	-	nocte, intron	nocte, exon_4	nocte		unadj_af=0.35; snp_su:0; snp_op:0	0.0
D050R24	52	Control-Freec	DUP	X	11110248	X	11128518	-	-	somatic_tumour	-	18.3	X:11110248-11128518	Heterozygous duplication	0.5	0.67	-	-	-	-	-	Hsp60A, exon_2	Gtp-bp, exon_2	Hsp60A, CG11122, Rpt3, Gtp-bp		unadj_af=0.33; snp_su:0; snp_op:0	0.0
D050R24	54	Control-Freec	DUP	X	15453288	X	15474690	-	-	somatic_tumour	-	21.4	X:15453288-15474690	Heterozygous duplication	0.5	0.46	-	-	-	-	-	intergenic	mh, exon_3	CG11655, shtd, CG6294, CG6299, CG15642, CG15641, Grip128, CG6308, mh		unadj_af=0.19; snp_su:0; snp_op:0	0.0
D050R24	56	Control-Freec	DUP	X	17661870	X	17667090	-	-	somatic_tumour	-	5.2	X:17661870-17667090	Heterozygous duplication	0.5	0.94	-	-	-	-	-	beta-Spec, exon_2	beta-Spec, exon_2	beta-Spec		unadj_af=0.47; snp_su:0; snp_op:0	0.0
D050R24	59	Control-Freec	DUP	X	19855314	X	19864188	-	-	somatic_tumour	-	8.9	X:19855314-19864188	Heterozygous duplication	0.5	0.83	-	-	-	-	-	Nup205, exon_6	CG15618, exon_4	Nup205, CG15618		unadj_af=0.44; snp_su:1; snp_op:1	5.12
D050R24	60	Control-Freec	DUP	X	20392452	X	20442564	-	-	somatic_tumour	-	50.1	X:20392452-20442564	Heterozygous duplication	0.5	0.43	-	-	-	-	-	Syx16, exon	CG1695, exon_5	Syx16, HERC2, CG15459, CG15458, Obp19a, Obp19b, Obp19c, Obp19d, Pp4-19C, cactin, CG15456, CG11710, mal, CG1695		unadj_af=0.2; snp_su:0; snp_op:0	0.0